{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Salarius Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"SLRX"},"Address":{"label":"Address","value":"2450 HOLCOMBE BOULEVARD,SUITE X, HOUSTON, Texas, 77021, United States"},"Phone":{"label":"Phone","value":"+1 832 834-6992"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Salarius Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing potential new cancer medicines for patients in need of new treatment options. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader."},"CompanyUrl":{"label":"Company Url","value":"https://www.salariuspharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"David J. Arthur","title":"President, Chief Executive Officer & Director"},{"name":"Rebecca Griffith Eskew","title":"Vice President-clinical operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}